154 related articles for article (PubMed ID: 32739935)
21. Unraveling Neuroendocrine Gallbladder Cancer: Comprehensive Clinicopathologic and Molecular Characterization.
de Bitter TJJ; Kroeze LI; de Reuver PR; van Vliet S; Vink-Börger E; von Rhein D; Jansen EAM; Nagtegaal ID; Ligtenberg MJL; van der Post RS
JCO Precis Oncol; 2021; 5():. PubMed ID: 34036234
[TBL] [Abstract][Full Text] [Related]
22. Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity.
Sahnane N; Furlan D; Monti M; Romualdi C; Vanoli A; Vicari E; Solcia E; Capella C; Sessa F; La Rosa S
Endocr Relat Cancer; 2015 Feb; 22(1):35-45. PubMed ID: 25465415
[TBL] [Abstract][Full Text] [Related]
23. Frequent and Specific Involvement of Changes of the p16-RB Pathway in Esophageal Neuroendocrine Carcinoma.
Fujimasa K; Ohike N; Norose T; Isobe T; Kikuchi K; Otsuka K; Murakami M; Takimoto M
Anticancer Res; 2019 Apr; 39(4):1927-1934. PubMed ID: 30952735
[TBL] [Abstract][Full Text] [Related]
24. Poorly differentiated neuroendocrine carcinomas of the gastrointestinal tract: A single-institute study of 43 cases.
Chen I; Zhang D; Velez M; Kovar S; Liao X
Pathol Res Pract; 2021 Oct; 226():153614. PubMed ID: 34555651
[TBL] [Abstract][Full Text] [Related]
25. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
[TBL] [Abstract][Full Text] [Related]
26. A case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder.
Okada H; Uchida Y; Matsuzaki N; Goto T; Nishimura S; Kurita A; Nishimura T; Yazumi S; Terajima H
World J Surg Oncol; 2016 Nov; 14(1):284. PubMed ID: 27842605
[TBL] [Abstract][Full Text] [Related]
27. Mutations in the RAS/RAF/MAP kinase pathway commonly occur in gallbladder adenomas but are uncommon in gallbladder adenocarcinomas.
Pai RK; Mojtahed K; Pai RK
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):133-40. PubMed ID: 21307665
[TBL] [Abstract][Full Text] [Related]
28. Two cases of neuroendocrine carcinoma of the gallbladder.
Chen H; Shen YY; Ni XZ
World J Gastroenterol; 2014 Sep; 20(33):11916-20. PubMed ID: 25206300
[TBL] [Abstract][Full Text] [Related]
29. Clinical, histopathologic, and immunohistochemical features of 13 cases of canine gallbladder neuroendocrine carcinoma.
O'Brien KM; Bankoff BJ; Rosenstein PK; Clendaniel DC; Sánchez MD; Durham AC
J Vet Diagn Invest; 2021 Mar; 33(2):294-299. PubMed ID: 33267749
[TBL] [Abstract][Full Text] [Related]
30. p16 overexpression in high-grade neuroendocrine carcinomas of the head and neck: potential diagnostic pitfall with HPV-related carcinomas.
Alos L; Hakim S; Larque AB; de la Oliva J; Rodriguez-Carunchio L; Caballero M; Nadal A; Marti C; Guimera N; Fernandez-Figueras MT; Quint W; Ordi J
Virchows Arch; 2016 Sep; 469(3):277-84. PubMed ID: 27392929
[TBL] [Abstract][Full Text] [Related]
31. HPV-associated neuroendocrine carcinomas of the head and neck in FNA biopsies: Clinicopathologic features of a rare entity.
Jo VY; Krane JF; Pantanowitz L; Monaco SE
Cancer Cytopathol; 2019 Feb; 127(1):26-34. PubMed ID: 30475447
[TBL] [Abstract][Full Text] [Related]
32. Grading of Neuroendocrine Carcinomas: Correlation of
Liverani C; Bongiovanni A; Mercatali L; Foca F; Pieri F; De Vita A; Spadazzi C; Miserocchi G; Recine F; Riva N; Nicolini S; Severi S; Martinelli G; Ibrahim T
Dis Markers; 2018; 2018():6878409. PubMed ID: 30627226
[TBL] [Abstract][Full Text] [Related]
33. Sarcomatoid carcinomas of the gallbladder: clinicopathologic characteristics.
Taskin OC; Akkas G; Memis B; Seven IE; Basturk O; Jang KT; Roa JC; Araya JC; Bellolio E; Losada H; Sarmiento J; Balci S; Pehlivanoglu B; Reid MD; Koshiol J; Adsay V
Virchows Arch; 2019 Jul; 475(1):59-66. PubMed ID: 31177317
[TBL] [Abstract][Full Text] [Related]
34. Neuroendocrine Carcinoma of the Endometrium: A Clinicopathologic Study of 25 Cases.
Pocrnich CE; Ramalingam P; Euscher ED; Malpica A
Am J Surg Pathol; 2016 May; 40(5):577-86. PubMed ID: 26945341
[TBL] [Abstract][Full Text] [Related]
35. Small cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases.
Maitra A; Tascilar M; Hruban RH; Offerhaus GJ; Albores-Saavedra J
Am J Surg Pathol; 2001 May; 25(5):595-601. PubMed ID: 11342770
[TBL] [Abstract][Full Text] [Related]
36. Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma.
Zhou HH; Liu LY; Yu GH; Qu GM; Gong PY; Yu X; Yang P
Anticancer Res; 2017 Aug; 37(8):4529-4537. PubMed ID: 28739749
[TBL] [Abstract][Full Text] [Related]
37. Comparative Outcomes in Patients With Small- and Large-Cell Neuroendocrine Carcinoma (NEC) and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm (MiNEN) of the Stomach.
Choi NY; Kim BS; Oh ST; Yook JH; Kim BS
Am Surg; 2021 Apr; 87(4):631-637. PubMed ID: 33142079
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic and Molecular Characterization of Anorectal Neuroendocrine Carcinomas Reveals Human Papillomavirus, p53, and c-Myc as Alternative Mechanisms of Carcinogenesis.
Cox AJ; Crowe WE; Yang Q; Zhang B; Oltvai ZN; Liao X
Mod Pathol; 2023 Nov; 36(11):100295. PubMed ID: 37517480
[TBL] [Abstract][Full Text] [Related]
39. Age-specific clinicopathological characteristics and prognostic analysis of neuroendocrine carcinomas of the gallbladder.
Zhang Z; Guo T; Huang X; Xie P; Wang L; Yu Y
Cancer Med; 2022 Feb; 11(3):641-653. PubMed ID: 34841738
[TBL] [Abstract][Full Text] [Related]
40. Moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the parotid gland: report of three cases with contemporary review of salivary neuroendocrine carcinomas.
Said-Al-Naief N; Sciandra K; Gnepp DR
Head Neck Pathol; 2013 Sep; 7(3):295-303. PubMed ID: 23456649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
